160 related articles for article (PubMed ID: 9216642)
21. Effect of whole body hyperthermia on carboplatin disposition and toxicity in dogs.
Page RL; McEntee MC; Williams PL; George SL; Price GS; Novotney CA; Hauck ML; Riviere JE; Dewhirst MW; Thrall DE
Int J Hyperthermia; 1994; 10(6):807-16. PubMed ID: 7884240
[TBL] [Abstract][Full Text] [Related]
22. Whole body hyperthermia supplemented with urotropin in the treatment of malignant tumors.
Ismail-Zade RS
Exp Oncol; 2005 Mar; 27(1):61-4. PubMed ID: 15812360
[TBL] [Abstract][Full Text] [Related]
23. Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin.
Xu Y; Choi J; Hylander B; Sen A; Evans SS; Kraybill WG; Repasky EA
Int J Hyperthermia; 2007 Sep; 23(6):513-27. PubMed ID: 17952765
[TBL] [Abstract][Full Text] [Related]
24. Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.
Ohno S; Strebel FR; Stephens LC; Siddik ZH; Baba H; Makino M; Khokhar AR; Bull JM
Br J Cancer; 1993 Sep; 68(3):469-74. PubMed ID: 8353037
[TBL] [Abstract][Full Text] [Related]
25. o-(beta-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment.
Bull JM; Strebel FR; Sunderland BA; Bulger RE; Edwards M; Siddik ZH; Newman RA
Cancer Res; 1988 Apr; 48(8):2239-44. PubMed ID: 3349489
[TBL] [Abstract][Full Text] [Related]
26. 41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases.
Atanackovic D; Nierhaus A; Neumeier M; Hossfeld DK; Hegewisch-Becker S
Cancer Immunol Immunother; 2002 Dec; 51(11-12):603-13. PubMed ID: 12439605
[TBL] [Abstract][Full Text] [Related]
27. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
[TBL] [Abstract][Full Text] [Related]
28. Hematological effects of radiant heat-induced whole body hyperthermia on dogs.
Woods JP; Schmitt-Tiggelaar CL; d'Oleire F; Rosenthal RC; Robins HI
Can J Vet Res; 1996 Jan; 60(1):75-8. PubMed ID: 8826000
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2.
Potapnev MP; Istomin YP; Ismail-zade RS; Zhavrid EA
Eksp Onkol; 2004 Mar; 26(1):67-70. PubMed ID: 15112583
[TBL] [Abstract][Full Text] [Related]
30. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
31. A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer.
Westermann AM; Grosen EA; Katschinski DM; Jäger D; Rietbroek R; Schink JC; Tiggelaar CL; Jäger E; Zum Vörde sive Vörding P; Neuman A; Knuth A; Van Dijk JD; Wiedemann GJ; Robins HI
Eur J Cancer; 2001 Jun; 37(9):1111-7. PubMed ID: 11378341
[TBL] [Abstract][Full Text] [Related]
32. Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer.
Hattori T; Kokura S; Okuda T; Okayama T; Takagi T; Handa O; Naito Y; Yoshida N; Yoshikawa T
Int J Hyperthermia; 2007 Nov; 23(7):591-8. PubMed ID: 18038289
[TBL] [Abstract][Full Text] [Related]
33. Whole-body hyperthermia combined with ifosfamide and carboplatin causes hypotension and nephrotoxicity.
Brauer LP; Prieshof B; Wiedemann GJ; Weiss C; Kriz W; Schramm U; Robins HI; Pagel H
J Cancer Res Clin Oncol; 1998; 124(10):549-54. PubMed ID: 9829858
[TBL] [Abstract][Full Text] [Related]
34. [Synergistic effect of carboplatin and hyperthermia in rat and human glioma cell lines].
Shinohara C; Matsumoto K; Maeda Y; Tada E; Kuriyama M; Adachi H; Ono Y; Higashi H; Furuta T; Ohmoto T
No Shinkei Geka; 1994 Nov; 22(11):1029-33. PubMed ID: 7816171
[TBL] [Abstract][Full Text] [Related]
35. Antitumor effect of carboplatin combined with radiation on tumors in mice.
Aratani Y; Yoshiga K; Mizuuchi H; Jo A; Tanimoto K; Sakurai K
Anticancer Res; 1997; 17(4A):2535-8. PubMed ID: 9252676
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.
Morgan RJ; Synold TW; Gandara D; Muggia F; Scudder S; Reed E; Margolin K; Raschko J; Leong L; Shibata S; Tetef M; Vasilev S; McGonigle K; Longmate J; Yen Y; Chow W; Somlo G; Carroll M; Doroshow JH
Cancer Chemother Pharmacol; 2004 Oct; 54(4):283-9. PubMed ID: 15184995
[TBL] [Abstract][Full Text] [Related]
37. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
38. Inhibition by whole-body hyperthermia with far-infrared rays of the growth of spontaneous mammary tumours in mice.
Udagawa Y; Nagasawa H; Kiyokawa S
Anticancer Res; 1999; 19(5B):4125-30. PubMed ID: 10628363
[TBL] [Abstract][Full Text] [Related]
39. Effect of whole-body hyperthermia on cell survival, metastasis frequency, and host immunity in moderately and weakly immunogenic murine tumors.
Urano M; Rice L; Epstein R; Suit HD; Chu AM
Cancer Res; 1983 Mar; 43(3):1039-43. PubMed ID: 6825078
[TBL] [Abstract][Full Text] [Related]
40. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
